P. Spirito

Cardiology and Cardiovascular Medicine · 2000–2014

A researcher in the Science corpus: 9 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

• Cardiology and Cardiovascular Medicine — 58 citations into it; #639 of 906 by trust here, #78 by citations

Whom P. Spirito trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. B. Maron
2. M. Maron

Who trusts P. Spirito overall

1. B. Maron
2. B. J. Gersh
3. Steve R. Ommen

Papers from P. Spirito's perspective

Ordered by how strongly the researchers P. Spirito trusts endorse each paper. Same corpus, a different order for every researcher.

1. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. (Journal of the American College of Cardiology)
2. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. (JACC Cardiovascular Imaging)
3. Assessment of Myocardial Fibrosis with Cardiac Magnetic Resonance (Journal of the American College of Cardiology)
4. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. (Journal of the American College of Cardiology)
5. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice… (Journal of Thoracic and Cardiovascular Surgery)
6. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond (Statistics in Medicine)
7. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors
8. Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy (Circulation)
9. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). (European Heart Journal)
10. Nonparametric Estimation from Incomplete Observations

Their papers

• Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy (2014) — 917 citations
• Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. (2014) — 632 citations
• Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. (2007) — 715 citations
• Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy (2006) — 637 citations
• Glycogen storage diseases presenting as hypertrophic cardiomyopathy. (2005) — 615 citations
• American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G (2003) — 1,383 citations
• Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. (2000) — 987 citations
• Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. (2000) — 811 citations
• Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. (2000) — 1,054 citations